Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 7, 2012, Pages 561-566

  Marini, M A ^a   Succurro, E ^b   Arturi, F ^b   Ruffo, M F ^b   Andreozzi, F ^b   Sciacqua, A ^b   Lauro, R ^a   Hribal, M L ^b   Perticone, F ^b   Sesti, G ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

2 h post load glucose; A1C; Fasting plasma glucose; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ITALY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

ADULT; BLOOD GLUCOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ITALY; MALE; MIDDLE AGED; RISK FACTORS; ROC CURVE;

EID: 84862131092     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.04.009     Document Type: Article

References (19)

1. Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(Suppl 1):S11-S61. American Diabetes Association.
2. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334. International Expert Committee.
3. Sesti G., Sciacqua A., Cardellini M., Marini M.A., Maio R., Vatrano M., et al. Plasma concentration of insulin-like growth factor-I is independently associated with insulin sensitivity in subjects with different degree of glucose tolerance. Diabetes Care 2005, 28:132-137.
4. Succurro E., Andreozzi F., Marini M.A., Lauro R., Hribal M.L., Perticone F., et al. Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects. Nutr Metab Cardiovasc Dis 2009, 19:713-719. 10.1016/j.numecd.2008.12.011.
5. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644.
6. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Int Med 1999, 130:461-470.
7. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 9:1462-1470.
8. Carson A.P., Reynolds K., Fonseca V.A., Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010, 33:95-97.
9. Cowie C.C., Rust K.F., Byrd-Holt D.D., Gregg E.W., Ford E.S., Geiss L.S., et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010, 33:562-568.
10. Kramer C.K., Araneta M.R., Barrett-Connor E. A1C and diabetes diagnosis: the Rancho Bernardo study. Diabetes Care 2010, 33:101-103.
11. Borg R., Vistisen D., Witte D.R., Borch-Johnsen K. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study. Diabet Med 2010, 27:906-910. doi:10.111/J1464-5491.2010.
12. Nathan D.M., Davidson M.B., DeFronzo R.A., Heine R.J., Henry R.R., Pratlet R., et al. Impaired fasting glucose and impaired glucose tolerance. implications for care. Diabetes Care 2007, 30:753-759.
13. Giaccari A., Sorice G., Muscogiuri G. Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment. Nutr Metab Cardiovasc Dis 2009, 19:365-377. 10.1016/j.numecd.2009.03.018.
14. Selvin E., Steffes M.W., Zhu H., Matsushita K., Wagenknecht L., Pankow J., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811.
15. Olson D.E., Rhee M.K., Herrick K., Ziemer D.C., Twombly J.G., Phillips L.S. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010, 33:2184-2189.
16. Lorenzo C., Haffner S.M. Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2010, 33:335-337.
17. Marques-Vidal P., Pécoud A., Hayoz D., Paccaud F., Mooser V., Waeber G., et al. Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. Nutr Metab Cardiovasc Dis 2010, 20:669-675. 10.1016/j.numecd.2009.06.001.
18. Herman W.H., Dungan K.M., Wolffenbuttel B.H., Buse J.B., Fahrbach J.L., Jiang H., et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab 2009, 94:1689-1694.
19. Lipska K.J., De Rekeneire N., Van Ness P.H., Johnson K.C., Kanaya A., Koster A., et al. Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab 2010, 95:5289-5295.